Elsevier Signs Up to Transparency Guidelines

The publisher will ask its journal editors to adopt widely accepted standards on transparency and openness in scientific communication.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, JOHANNES JANSSONElsevier, the publishing giant currently embroiled in disputes over open access to journal articles, has now become a signatory to scientific publishing’s Transparency and Openness Promotion Guidelines, according to an announcement made today (September 5) with the Center for Open Science (COS). The guidelines, published in June 2015 in Science by a committee of researchers, funding agency representatives, and journal editors from Europe and North America, detail eight standards designed to foster greater transparency in scientific communication in journals that publish research.

“Elsevier journals now encourage and enable authors to share data or make a data availability statement, which is part of our ongoing focus on research integrity and supporting good quality research,” Philippe Terheggen, Elsevier’s managing director of science, technical, and medical journals, says in a press release. “We look forward to strengthening our work with COS and will provide feedback from authors and editors, to develop the best possible solutions to promote reproducibility, transparency and quality of research.”

The published guidelines—which have already been adopted by AAAS, Springer Nature, Wiley, and others—include recommendations on how authors should present data and research materials, and lay out various degrees of stringency for their adoption at journals. For example, a level one adoption of the “data transparency” standard ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies